For & Against
What's Next
The next six months hinge on a single data point: Blue Moon's H1 2026 selling expense ratio. Everything else — the buyback, the dividend, the analyst upgrades — is noise until that number prints.
What the market is watching most closely: The H1 2026 interim results, expected August 2026. Both the bull and bear cases collapse or confirm on the S&D ratio. Bull needs it below 48% with stable revenue. Bear expects it back above 50%. Q4 2025's quarterly profit of HK$53M was encouraging but covered just one quarter — the interim will show whether cost discipline survives a full half-year.
China's regulatory push toward concentrated detergent formats and energy-efficient washing provides a modest structural tailwind for Blue Moon's Zhizun product line, but it is a slow-moving industry trend, not a near-term catalyst.
For / Against / My View
For
1. 60% gross margin proves the moat is real
Blue Moon's gross margin has held between 58% and 65% for six consecutive years through COVID, raw material spikes, a complete channel mix overhaul, and China's fiercest consumer downturn in a generation. This is not a commodity business — it is a brand franchise with structural economics superior to P&G (51%), Unilever (42%), and every listed peer. Sixteen consecutive years as China's #1 liquid laundry detergent brand by market share is a moat that has never been seriously tested by a competitor.
Evidence: gross margin 64.5% (FY2020), 58.4% (FY2021), 57.8% (FY2022), 62.0% (FY2023), 60.6% (FY2024), 59.7% (FY2025) — six years of stability through massive channel disruption. Highest gross margin in the peer group, above P&G, Unilever, Henkel, Kao, and Shanghai Jahwa.
2. The S&D inflection is proven — each point is HK$84M
S&D expenses dropped from 59.0% to 53.1% of revenue in FY2025 — a 6-percentage-point improvement that saved roughly HK$500M and cut the net loss by 56% from HK$749M to HK$329M. Q4 2025 returned to quarterly profit (HK$53M net income), demonstrating that the business generates positive earnings at current revenue levels when S&D is controlled. Every additional percentage point of S&D reduction on HK$8.4B of revenue drops HK$84M directly to operating income. The path from 53% to 40% represents HK$1.1B of incremental operating income — enough to restore double-digit operating margins without any revenue growth.
Evidence: FY2025 S&D ratio 53.1% vs 59.0% in FY2024; Q4 2025 net income HK$53M. Each 1pp S&D improvement = HK$84M operating income; path to 40% S&D = ~9% operating margin on flat revenue.
3. Founder down HK$43B with buyback loaded
Pan Dong owns 73.78% and has suffered approximately HK$43B in paper losses since IPO — more economic pain than any minority shareholder will ever bear. She invested her entire career (founded 1992, 34 years) in this single asset. In March 2026 the board authorized a 10% share buyback (586M shares), which at current prices represents HK$1.8B of buying power — nearly half the remaining cash pile, signaling that the founder views the stock as deeply undervalued. Hillhouse Capital (HHLR Advisors) retains its 8.99% pre-IPO stake and has barely reduced.
Evidence: Pan Dong 73.78% ownership, ~HK$43B paper loss from IPO peak; 10% buyback authorization March 2026; HHLR Advisors 8.99% retention.
Bull price target: HK$5.00 (60% upside from HK$3.13). Timeline: 18–24 months through FY2026 and FY2027 results seasons. Methodology: 30x P/E on ~HK$900M FY2027E normalized net income, assuming S&D normalizes to 38% of revenue. Disconfirming signal: S&D ratio re-accelerating above 55% in any reported half-year.
Against
1. S&D spend destroyed a profitable business — the "fix" is unproven
Blue Moon doubled selling expenses from 29% to 59% of revenue between FY2020 and FY2024, converting HK$1,746M operating profit into a HK$1,004M operating loss — a HK$2,750M swing driven entirely by one line item. The FY2025 pullback to 53% still leaves S&D nearly double the FY2020 level, and revenue fell 1.7% — the HK$5,049M spent on S&D in FY2024 failed to hold the top line. One year of partial improvement does not constitute a trend, and S&D at 53% remains roughly double the level at which this business was profitable.
Evidence: S&D ratio 29% (FY2020) → 59% (FY2024) → 53% (FY2025); operating income swung from +HK$1,746M to -HK$1,004M to -HK$355M. Revenue declined 1.7% in FY2025 despite HK$5,049M in selling spend the prior year.
2. IPO cash halved — dividends exceed earnings by HK$1,900M
Net cash has collapsed from HK$10,921M to HK$3,716M in five years. The company paid HK$4,100M in cumulative dividends against HK$2,200M in cumulative net income — the HK$1,900M gap was funded from IPO proceeds. FY2025 paid HK$585M in dividends on a HK$329M net loss, explicitly drawn from the share premium account. At the current burn rate of ~HK$1,500M per year, cash exhausts by FY2028, forcing a dividend cut, a capital raise, or both.
Evidence: cumulative dividends HK$4,100M vs cumulative NI HK$2,200M; Pan Dong received ~HK$3,000M via her 73.78% stake. Net cash HK$10,921M (FY2020) → HK$3,716M (FY2025). Only HK$577M of IPO proceeds remain unutilized.
3. Five years of broken guidance destroy management credibility
Management promised profitability improvement every year from FY2021 through FY2024 and missed every single time — profit fell from HK$1,309M to a HK$749M loss. They introduced non-HKFRS metrics in FY2022 to mask the decline, then quietly abandoned them when the tailwind faded. They retroactively reframed a 56% S&D cost overrun in FY2024 as "strategic investment." The FY2025 "cost optimization" narrative appeared for the first time that year — absent in all prior disclosures — confirming the FY2024 blowout was unplanned.
Evidence: credibility score 3/10; four consecutive guidance misses plus one partial. "Cost optimization" absent as management theme until FY2025. Board lacks digital/e-commerce expertise despite 59% online revenue dependency; no succession plan disclosed for the founder-couple running the company.
Bear downside target: HK$1.80 (42% downside from HK$3.13). Timeline: 12–18 months through H1 2027 results. Methodology: EV/Sales compression to 1.0x on flat HK$8,400M revenue with net cash reduced to ~HK$2,500M after 12 months of burn. Trigger: H1 2026 S&D ratio above 50%, confirming FY2025 was transient. Covering signal: two consecutive quarters of S&D below 45% with stable or growing revenue.
The Tensions
1. S&D at 53%: structural inflection or revenue sacrifice?
Bull says the 6-percentage-point improvement from 59% to 53% proves the company can control costs, and each further point adds HK$84M to operating income. Bear says the improvement came with a 1.7% revenue decline — the company spent less because it sold less, not because it became more efficient. Both cite the same number: FY2025 S&D at 53.1% of revenue on HK$8,409M in sales. This resolves on the H1 2026 interim results: if S&D falls below 48% while revenue holds flat or grows, the inflection is structural. If revenue falls further to achieve the next S&D reduction, it is not.
2. Pan Dong's 73.78%: alignment or extraction?
Bull says the founder has suffered HK$43B in paper losses and authorized a HK$1.8B buyback, proving she views the stock as deeply undervalued and her interests are aligned with minorities. Bear says Pan Dong has received approximately HK$3,000M in dividends through her 73.78% stake — funded from IPO proceeds, not earnings — while the business lost money in two of the last three years. Both cite the same fact: a 74% founder who controls all capital allocation decisions. This resolves on whether the buyback is executed at meaningful scale and whether dividends are cut when the cash pile drops below HK$2.5B — or whether founder extraction continues regardless.
3. The FY2025 partial: first promise kept, or five-year pattern?
Bull points to the FY2025 loss reduction of 56%, the Q4 quarterly profit of HK$53M, and the buyback authorization as evidence that management has finally delivered. Bear points to four consecutive years of missed profitability guidance (FY2021–FY2024), the appearance and disappearance of non-HKFRS metrics, and the retroactive "strategic investment" reframe — arguing one partial delivery does not break a five-year pattern. Both cite the same management track record. This resolves on whether H1 2026 results match or exceed the forward guidance management provides over the next three months — one more miss and the pattern is cemented.
My View
I lean cautious. The Against side is heavier here — not because the product is bad (the 60% gross margin is real and structurally impressive), but because the stock at HK$3.13 already trades 25% above analyst consensus and prices in a turnaround that has only one quarter of supporting evidence after five years of deterioration. The central tension — whether S&D at 53% is an inflection or a one-year cut achieved by shrinking revenue — tips the scale toward waiting. Management's credibility deficit after four straight misses means the FY2025 improvement needs confirmation before it earns the benefit of the doubt. I would wait for H1 2026 results: if S&D prints below 48% on flat or growing revenue, the setup becomes genuinely compelling and worth revisiting. Until then, the risk-reward favors patience over conviction.